The compound camphor ointment market has seen considerable growth due to a variety of factors.
• The compound camphor ointment market has grown steadily in recent years. It will increase from $2.55 billion in 2024 to $2.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%.
The market’s growth is driven by the rising popularity of topical analgesics, an aging population, and the increasing demand for natural remedies.
The compound camphor ointment market is expected to maintain its strong growth trajectory in upcoming years.
• The compound camphor ointment market is projected to grow to $3.35 billion by 2029, with a CAGR of 5.6%.
The growth is driven by increasing musculoskeletal disorder prevalence, the aging population, higher healthcare spending, and the rising popularity of traditional medicine. Trends include innovative formulations, advanced medical technologies, and partnerships.
The increasing prevalence of musculoskeletal disorders is expected to fuel the growth of the compound camphor ointment market. Musculoskeletal disorders, caused by repetitive motion and poor posture, are rising globally. Compound camphor ointment, known for its analgesic and anti-inflammatory properties, is widely used for treating these disorders. For example, in October 2023, the Institute for Health Metrics and Evaluation (IHME) projected a 115% increase in musculoskeletal disorders in the U.S. from 2020 to 2050, driving the demand for compound camphor ointment.
The compound camphor ointment market covered in this report is segmented –
1) By Formulation: Internal Use, Topical Use
2) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By Application: Pain Relief, Anti-Itching, Fungal Infection, Other Applications
Subsegments:
1) By Internal Use: Camphor Capsules, Camphor Tablets, Camphor Liquids For Oral Consumption
2) By Topical Use: Camphor Creams, Camphor Ointments, Camphor Gels
Companies in the compound camphor ointment market are focusing on developing pain relief topical solutions that leverage camphor’s therapeutic properties for pain and anti-inflammatory benefits. For example, in September 2024, Mankind Pharma, Ltd., an India-based pharmaceutical company, launched Sofgel Neck Pain Relief, a topical solution designed to relieve neck pain caused by muscle strain, poor posture, or injury. The product targets pain at the source, providing effective and accessible relief.
Major companies operating in the compound camphor ointment market are:
• CVS Health
• McKesson
• Cigna Corp.
• Johnson & Johnson
• China Resources Sanjiu Medical & Pharmaceutical Co. Ltd.
• Cipla Limited
• Greenbrier International Inc.
• Mallinckrodt Plc
• Emcure Pharmaceuticals Limited
• Vi-jon Laboratories
• Oriental Aromatics Ltd.
• Amrutanjan Health Care limited
• Delon Laboratories Inc.
• Mentholatum Company
• Frey & Lau GmbH
• Indiana botanic gardens
• DLC Laboratories Inc.
• GHC Group LLC
• Focus Consumers Health care LLC
• Caribe Natural LLc
• Emu Joy
• Himalaya Wellness Co.
• AVN Ayurveda Formulations Pvt. Ltd.
• Ilesol Pharmaceuticals
• Thera Wise
North America was the largest region in compound camphor ointment in 2023.North America is expected to be the fastest-growing region in the forecast period. The regions covered in the compound camphor ointment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.